Acadia Pharmaceuticals Inc.
ACAD
ACAD: Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
moreShow ACAD Financials
Recent trades of ACAD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACAD's directors and management
Government lobbying spending instances
-
$230,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$390,000 Apr 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$370,000 Jan 19, 2023 Issue: Defense Budget/Appropriations Medicare/Medicaid Health Issues
-
$260,000 Oct 19, 2022 Issue: Defense Budget/Appropriations Medicare/Medicaid Health Issues
-
$310,000 Aug 18, 2022 Issue: None
-
$230,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
-
$200,000 Jan 20, 2022 Issue: None
-
$210,000 Oct 19, 2021 Issue: None
-
$210,000 Jul 19, 2021 Issue: None
-
$220,000 Apr 20, 2021 Issue: None
-
$190,000 Jan 20, 2021 Issue: None
-
$10,000 Oct 16, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$10,000 Jul 15, 2020 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Apr 16, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$20,000 Jan 21, 2020 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Oct 21, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Jul 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Apr 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Jan 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$20,000 Oct 22, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
New patents grants
Federal grants, loans, and purchases
Followers on ACAD's company Twitter account
Number of mentions of ACAD in WallStreetBets Daily Discussion
Recent insights relating to ACAD
Recent picks made for ACAD stock on CNBC
ETFs with the largest estimated holdings in ACAD
Flights by private jets registered to ACAD